Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT
NCT ID: NCT04931901
Last Updated: 2022-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-09-06
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography
NCT06409260
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
NCT05120999
Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System
NCT04406740
Electromyographic Assessment of the TetraGraph in Normal Volunteers
NCT02912039
Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting
NCT04352140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stimpod NMX450X
EMG TOF device
Use of Stimpod NMX450X as an electromyographic neuromuscular monitor
Datex-Ohmeda E-NMT
EMG TOF device
Use of Stimpod NMX450X as an electromyographic neuromuscular monitor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMG TOF device
Use of Stimpod NMX450X as an electromyographic neuromuscular monitor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing General Anaesthesia for noncardiac surgery requiring the use of a neuromuscular blocking agent.
Exclusion Criteria
* Known Neuromuscular diseases/syndromes judged to condition accurate neuromuscular monitoring.
* Known acute or chronic hepatic disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
StimpodVSDatex-Ohmeda
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.